Increased Plasma Heparanase Activity in COVID-19 PatientsBaranca Buijsers, Johan van der Vlag, Mark de Graaf et al.|Frontiers in Immunology|2020Cited by 136
Increased plasma heparanase activity in COVID-19 patientsBaranca Buijsers, Johan van der Vlag, Cansu Yanginlar et al.|medRxiv|2020Cited by 17
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuriaMarjolein Garsen, Johan van der Vlag, Baranca Buijsers et al.|EBioMedicine|2023Cited by 8
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritisBaranca Buijsers, Johan van der Vlag, Maaike Jacobs et al.|Frontiers in Molecular Biosciences|2023Cited by 8